ARK Investment Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-485,658
| Closed | -$232M | – | 299 |
|
|
2021
Q2 | $232M | Sell |
485,658
-107,139
| -18% | -$51.1M | 0.43% | 57 |
|
|
2021
Q1 | $244M | Sell |
592,797
-94,266
| -14% | -$38.8M | 0.48% | 56 |
|
|
2020
Q4 | $337M | Buy |
687,063
+72,411
| +12% | +$35.5M | 0.9% | 36 |
|
|
2020
Q3 | $348M | Sell |
614,652
-9,295
| -1% | -$5.26M | 2.06% | 13 |
|
|
2020
Q2 | $59.4M | Buy |
623,947
+191,581
| +44% | +$18.2M | 0.64% | 34 |
|
|
2020
Q1 | $30.9M | Buy |
432,366
+68,674
| +19% | +$4.9M | 0.77% | 31 |
|
|
2019
Q4 | $25.1M | Buy |
363,692
+9,944
| +3% | +$686K | 0.63% | 36 |
|
|
2019
Q3 | $28.4M | Buy |
353,748
+1,804
| +0.5% | +$145K | 0.62% | 40 |
|
|
2019
Q2 | $22.7M | Buy |
351,944
+87,558
| +33% | +$5.64M | 0.57% | 37 |
|
|
2019
Q1 | $36.3M | Buy |
264,386
+58,412
| +28% | +$8.03M | 1.04% | 29 |
|
|
2018
Q4 | $18.6M | Buy |
205,974
+3,937
| +2% | +$356K | 0.76% | 30 |
|
|
2018
Q3 | $30.7M | Buy |
202,037
+38,716
| +24% | +$5.88M | 0.93% | 36 |
|
|
2018
Q2 | $28.1M | Buy |
163,321
+42,985
| +36% | +$7.39M | 1.03% | 35 |
|
|
2018
Q1 | $17.7M | Buy |
120,336
+39,061
| +48% | +$5.73M | 0.88% | 39 |
|
|
2017
Q4 | $16.5M | Buy |
81,275
+36,629
| +82% | +$7.43M | 1.31% | 35 |
|
|
2017
Q3 | $14.3M | Buy |
44,646
+6,386
| +17% | +$2.05M | 1.75% | 22 |
|
|
2017
Q2 | $8.65M | Buy |
38,260
+6,764
| +21% | +$1.53M | 1.68% | 24 |
|
|
2017
Q1 | $7.1M | Buy |
31,496
+6,893
| +28% | +$1.55M | 2.05% | 17 |
|
|
2016
Q4 | $4.87M | Buy |
+24,603
| New | +$4.87M | 1.77% | 18 |
|